Koji Izutsu

37PUBLICATIONS
156CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Apr 16, 2026
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.

|Mar 02, 2026
Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Marta Canelo-Vilaseca, Mohamad Sabbah, Caterina Cristinelli

|Jan 08, 2026
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Marta Canelo-Vilaseca, Mohamad Sabbah, Caterina Cristinelli

|Sep 25, 2025
Bridging gaps in clinical trial accessibility and reimbursement for large B-cell lymphoma therapies across Europe.

Florence Broussais, Elise Pennings, Natacha Bolanos

|Apr 25, 2025
Author Correction: T cell malignancies after CAR T cell therapy in the DESCAR-T registry.

Remy Dulery, Vincent Guiraud, Sylvain Choquet

|Apr 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag

Pageof 7

Frequent Collaborators

9 joint publications

Emmanuel Bachy

8 joint publications

René-Olivier Casasnovas

8 joint publications

Sylvain Choquet

7 joint publications

Roch Houot